GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Net Policyholder Benefits/Claims

Microbix Biosystems (TSX:MBX) Net Policyholder Benefits/Claims


View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


Microbix Biosystems (TSX:MBX) Business Description

Industry
Traded in Other Exchanges
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.
Executives
James Stuart Currie Senior Officer